-
Nature Biotechnology6 months ago
Generalist biological artificial intelligence in modeling the language of life
Nature Biotechnology, Published online: 20 March 2026; doi:10.1038/s41587-026-03064-w This Review discusses the promises and pitfalls of biological AI algorithms and presents a vision for generalist biological...
-
Nature Biotechnology6 months ago
Functional integration of an autologous engineered esophagus in a large-animal model
Nature Biotechnology, Published online: 20 March 2026; doi:10.1038/s41587-026-03043-1 A tissue-engineered esophageal segment is functional in minipigs.
-
AI, Machine Learning & Computational Biology6 months agoDrug development is booming in China. Should the U.S. view it as a threat or an opportunity?
If the U.S. wants to hold on to its title as the world’s top biotech innovator, it might want to take a page out of China’s...
-
AI, Machine Learning & Computational Biology6 months agoIndependent autism committee kicks off efforts to counter RFK Jr., influence Congress
WASHINGTON — Autism scientists and advocates met Thursday to develop an agenda for autism research, the first gathering of a group that hopes to command the...
-
Endpoints News6 months ago
Tech talent comes to healthcare
In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a $10...
-
GEN – Genetic Engineering & Biotechnology News6 months agoCommercializing Autologous Cell Therapy: Bridging Clinical and Large-Scale Manufacturing
Register Now Panelists: Pascal Touchon Operating Partner, Jeito CapitalChair & Member of Board of Directors, Advisor, RoslinCT View Bio Panelist Pascal Touchon Pascal Touchon serves as...
-
GEN – Genetic Engineering & Biotechnology News6 months ago
Baylor College of Medicine Taps Nautilus’ Voyager for Cancer Proteomics
Nautilus Biotechnology has announced Baylor College of Medicine as the first customer of the early access program for its proteomics technology. As part of the program,...
-
GEN – Genetic Engineering & Biotechnology News6 months agoNovel Schizophrenia Biomarker and Potential Therapeutic Strategy Identified
Current schizophrenia (SZ) medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms, such as disorganized thinking or executive dysfunction. As a...
-
Fierce Biotech6 months ago
Verily banks $300M to accelerate AI road map, transitions to independent company
Verily raised a $300 million investment round to accelerate its work in artificial intelligence and precision health as it also moves out from under the corporate...
-
BioPharma Dive – AI / Data6 months agoNovo uses FDA voucher to win speedy approval of higher-dose Wegovy
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
Deep dive: Psychedelics back on FDA’s doorstep
‘Patients are not a renewable resource’: Rethinking rare disease R&D
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
